Moelis posts record Q2 revenue, raises dividend to $0.65

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Moelis & Company achieved record second-quarter revenues of $409.4 million and adjusted EPS of $0.63, outperforming analyst expectations. The investment bank expanded its pre-tax margin to 18.6% and declared a $0.65 quarterly dividend, while maintaining a debt-free balance sheet with $481.1 million in cash.

powered bylight_fuzz_icon
46917680

*this image is generated using AI for illustrative purposes only.

Moelis & Company delivered record second-quarter revenues of $409.4 million, up 12 percent year-over-year, driving adjusted earnings per share (EPS) to $0.63. The New York-based investment bank surpassed analyst consensus of $0.62 by 1.61 percent, while GAAP net income reached $55.1 million. The strong top-line performance was underpinned by an increase in average fees earned per completed transaction. Alongside the results, the Board of Directors declared a regular quarterly dividend of $0.65 per share, payable on September 17, 2026, to stockholders of record on August 10, 2026.

The firm’s operational efficiency improved as adjusted pre-tax margins expanded to 18.6 percent from 17.6 percent in the prior year period. Total operating expenses on a GAAP basis were $336.6 million, reflecting a 10 percent increase primarily due to higher compensation and benefits costs linked to increased headcount. Non-compensation expenses rose 28 percent to $67.2 million, driven by deal-related travel, client conferences, and investments in artificial intelligence technology.

Financial Performance Overview

Metric Q2 Actual Estimate Variance YoY Change
Revenues $409.4M $385.5M +6.20% +12%
Adjusted EPS $0.63 $0.62 +1.61% +19%
GAAP Net Income $55.1M — — +18%
Adj. Pre-tax Margin 18.6% — — +100 bps

For the first half of 2026, revenues totaled $729.2 million, a 9 percent increase from the prior year period. Adjusted net income for the six-month period was $97.2 million, or $1.13 per share (diluted), compared with $99.9 million, or $1.17 per share, in the same period last year. The decline in first-half adjusted EPS is attributable to reduced net tax benefits from share-based award settlements in 2026 ($0.11 per share) versus the prior year ($0.28 per share).

Strategic Expansion and Capital Return

Moelis & Company continued executing its growth strategy by adding six Managing Directors year-to-date, focusing on Private Credit Secondaries, Securitization, Debt Capital Markets, Energy, Chemicals, and Healthcare IT. Six additional Managing Directors are committed to join later this year, including hires in Private Capital Advisory and Europe-focused Sponsors and Infrastructure roles.

The firm maintained a strong balance sheet with cash and short-term investments of $481.1 million and no debt as of June 30, 2026. During the second quarter, Moelis repurchased 0.3 million shares at an average price of $64.43 per share. Including the newly declared dividend, the firm returned a total of $246.4 million to shareholders in the first half of 2026.

What the Numbers Show

The divergence between the 19 percent surge in adjusted EPS and the 12 percent growth in revenue highlights significant operating leverage. While revenue expanded solidly, profitability accelerated faster, suggesting that fixed costs were spread over a larger income base. This efficiency is further evidenced by the expansion in adjusted pre-tax margins, which widened by 100 basis points year-over-year. The firm’s ability to grow margins while investing in new talent and technology indicates disciplined cost management and a favorable mix of higher-margin advisory transactions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Moelis' targeted hiring in Private Credit Secondaries and Securitization position the firm to capture market share as these specialized deal flows accelerate?

What is the expected ROI timeline for the significant increase in non-compensation expenses, particularly regarding investments in artificial intelligence technology?

Given the strong operating leverage and margin expansion, will management consider increasing the pace of share repurchases or adjusting dividend policy in the second half of 2026?

like19
dislike

Keefe, Bruyette & Woods lowers Moelis target to $66

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Keefe, Bruyette & Woods analyst Aidan Hall maintained Moelis with a Market Perform rating and lowered the price target to $66 from $69. This contrasts with UBS analyst Michael Brown, who downgraded the stock to Sell while raising the price target to $60 from $58.

powered bylight_fuzz_icon
45048680

*this image is generated using AI for illustrative purposes only.

Keefe, Bruyette & Woods analyst Aidan Hall maintained Moelis with a Market Perform rating and lowered the price target to $66, reducing the outlook from the previous $69. This adjustment follows a separate downgrade by UBS analyst Michael Brown, who shifted the stock from Neutral to Sell with a raised price target of $60, up from $58.

Rating and Price Action

The consensus among analysts shows a divergence in outlook for the stock. While Keefe, Bruyette & Woods retains a neutral stance, UBS has adopted a more bearish position despite a modest increase in its price target.

Firm Rating Price Target Previous Target
Keefe, Bruyette & Woods Market Perform $66 $69
UBS Sell $60 $58
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors are driving the divergence in analyst ratings between KBW and UBS?

How might Moelis's recent financial performance influence future analyst adjustments?

What impact could these downgrades have on investor sentiment toward Moelis?

like16
dislike

More News on Moelis & Co